Tue 7/17/2018 09:46 ET
DJIA24996.9367.430.27%TELCO161.390.680.42%GOLD1232.007.640.62%Shanghai2798.1315.950.57%
S&P 5002791.886.420.23%BANKS472.030.140.03%OIL66.560.510.77%BITCOIN6710.9829.530.44%
NASDAQ7777.0028.770.37%PHARM522.315.120.98%US/EU1.170.000.26%Futures2804.506.000.21%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Protalix BioTherapeutics - PLX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add PLX
  
From: ZackMorris (Rep: 0)Date: 01/02/2018 08:27
Forum: Protalix BioTherapeutics - Msg #340Thread #673978230 (Rec: 0)
$PLX Protalix BioTherapeutics Reports Positive Interim Data from Phase II Clinical Trial of OPRX-106 in Patients with Ulcerative Colitis



Zack Attack!



NOTE: This message was originally posted on 2018-01-02 07:03:28 by the ZackMorris.

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser ZackMorris: Reward | Watch | IgnorePLX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add PLX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.